Trademark: 85368484
Word
POWERING BETTER PRODUCTS WITH NEXT GENERATION SYNTHETIC BIOLOGY
Status
Dead
Status Code
606
Status Date
Monday, December 28, 2015
Serial Number
85368484
Mark Type
4000
Filing Date
Monday, July 11, 2011
Published for Opposition
Tuesday, October 2, 2012
Abandoned Date
Monday, December 28, 2015

Trademark Owner History
Intrexon Corporation - Owner At Publication

Classifications
1 Chemicals, biochemicals and reagents for use in industry and science; Chemicals for use in biochemical and chemical industry; chemicals for use in agriculture; chemicals for use in biotechnological product development; chemicals for use in biotechnological manufacturing processes; chemical preparations for scientific purposes; chemical reagents for non-medical purposes; chemicals, biochemicals and reagents, namely, proteins for regulating, modifying or restricting gene expression, ligands, genetic vectors, genetic hosts, genetic biochemicals, genetic bioengineering reagents and proteins for use in regulating cellular functions in transgenic plants, fungi and animals, and in cells of plants, fungi and animals; Chemical inducers of gene expression in plants, mammals, fungi and bacteria for industrial and agricultural applications
5 Chemical preparations for medical and veterinary purposes, namely, proteins for use in treating disease states, for treating genetic disorders, and for use as medical and veterinary diagnostic reagents; Chemical preparations for medical and veterinary purposes, namely, chemical preparations for gene therapy, for treating genetic disorders, and for use as medical and veterinary diagnostic reagents for gene therapy analysis; biochemical preparations for medical and veterinary purposes, namely, biochemical preparations for gene therapy, for treating genetic disorders, and for use as medical and veterinary diagnostic reagents for gene therapy analysis; Chemical inducers of gene expression in plants, mammals, fungi and bacteria for medical and veterinary applications; Chemicals and chemical reagents, namely, cells of transgenic animals, transgenic plants and transgenic fungi, and cells of animals, plants or fungi for use in medical, pharmaceutical and veterinary laboratory research; Pharmaceutical and veterinary preparations which regulate the cellular functions of fungi, plants, bacteria and mammals and transgenic fungi, plants, bacteria and mammals; transgenic fungi and bacteria for medical and veterinary purposes; Chemicals biochemicals and reagents for veterinary and medical use, namely, chemical, biochemicals and reagents for regulating, modifying or restricting gene expression, ligands, genetic vectors, genetic hosts, genetic biochemicals, genetic bioengineering reagents and proteins for use in regulating cellular functions, and gene expression inducers
40 Custom manufacturing and custom synthesis of genetically engineered DNA, biological organisms, cells, viruses, pathogens and special purpose cells to the specifications of others for scientific, research, medical and laboratory use
42 Development of new technology for others in the field of genetics, therapeutics and biotechnology; Development of products being genetic therapies and effectors to regulate, modulate, and characterize disease states; Development of tools in the nature of software and biotechnological processes to regulate, modulate, and characterize disease states; Research and development services for others in the fields of biotechnology and genetics, namely, genetically engineering DNA, biological organisms, cells, viruses, pathogens, and special purpose cells for scientific, research, medical and laboratory use; Scientific research and product development services for others in the pharmaceutical, biotechnology, biosensors, bioelectronics, medical and agriculture fields; Gene therapy services for others for product development and scientific research purposes, namely, genetically engineering DNA, biological organisms, cells, viruses, pathogens, and special purpose cells for scientific, research, medical and laboratory use
44 Medical services; Medical services, namely, gene therapy services
45 Technology transfer services, namely, licensing and transfer of intellectual property

Trademark Events
Apr 18, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Apr 18, 2020
Teas Change Of Correspondence Received
Apr 18, 2020
Teas Withdrawal Of Attorney Received-Firm Retains
Apr 18, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 18, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 18, 2020
Teas Change Of Owner Address Received
Dec 28, 2015
Abandonment Notice Mailed - No Use Statement Filed
Dec 28, 2015
Abandonment - No Use Statement Filed
May 29, 2015
Notice Of Approval Of Extension Request E-Mailed
May 28, 2015
Extension 5 Granted
May 27, 2015
Extension 5 Filed
May 27, 2015
Teas Extension Received
Nov 26, 2014
Notice Of Approval Of Extension Request E-Mailed
Nov 25, 2014
Extension 4 Granted
Nov 24, 2014
Extension 4 Filed
Nov 24, 2014
Teas Extension Received
May 23, 2014
Notice Of Approval Of Extension Request E-Mailed
May 22, 2014
Extension 3 Granted
May 21, 2014
Extension 3 Filed
May 21, 2014
Teas Extension Received
Jan 15, 2014
Notice Of Approval Of Extension Request E-Mailed
Jan 14, 2014
Extension 2 Granted
Nov 19, 2013
Extension 2 Filed
Dec 31, 2013
Case Assigned To Intent To Use Paralegal
Nov 19, 2013
Teas Extension Received
Mar 2, 2013
Notice Of Approval Of Extension Request E-Mailed
Feb 28, 2013
Extension 1 Granted
Feb 28, 2013
Extension 1 Filed
Feb 28, 2013
Teas Extension Received
Nov 27, 2012
Noa E-Mailed - Sou Required From Applicant
Oct 2, 2012
Official Gazette Publication Confirmation E-Mailed
Oct 2, 2012
Published For Opposition
Sep 12, 2012
Notification Of Notice Of Publication E-Mailed
Aug 28, 2012
Law Office Publication Review Completed
Aug 28, 2012
Assigned To Lie
Aug 16, 2012
Approved For Pub - Principal Register
Aug 14, 2012
Teas/Email Correspondence Entered
Aug 13, 2012
Correspondence Received In Law Office
Aug 13, 2012
Teas Request For Reconsideration Received
May 21, 2012
Notification Of Final Refusal Emailed
May 21, 2012
Final Refusal E-Mailed
May 21, 2012
Final Refusal Written
Apr 28, 2012
Teas/Email Correspondence Entered
Apr 27, 2012
Correspondence Received In Law Office
Apr 27, 2012
Teas Response To Office Action Received
Nov 1, 2011
Notification Of Non-Final Action E-Mailed
Nov 1, 2011
Non-Final Action E-Mailed
Nov 1, 2011
Non-Final Action Written
Oct 25, 2011
Assigned To Examiner
Jul 14, 2011
New Application Office Supplied Data Entered In Tram
Jul 14, 2011
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24